Sensei Biotherapeutics In...
(SNSE) ✕
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
undefined
undefined%
At close: undefined
0.51
-2.28%
After-hours Jan 06, 2025, 07:52 PM EST
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
PE Ratio | -0.57 | -0.94 | -4.29 | -28.02 | -29.18 | -0.99 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 0.30 | 0.44 | 1.10 | -10.24 | -8.07 | -0.24 |
P/FCF Ratio | -0.6 | -1.16 | -4.98 | -30.57 | -64.27 | -1.25 |
P/OCF Ratio | -0.6 | -1.17 | -5.31 | -32.65 | -64.67 | -1.26 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | n/a | 0.02 | 0.00 | -0.01 | -0.23 | -0.09 |
Quick Ratio | 11.92 | 11.98 | 30.38 | 4.16 | 0.02 | 0.48 |
Current Ratio | 11.92 | 11.98 | 30.38 | 4.16 | 0.02 | 0.48 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | -257.39 | -229.17 | -55.94 | -11.52 | -5.51 | -38.96 |
Return on Equity (ROE) | -0.53 | -0.47 | -0.26 | 0.37 | 0.28 | 0.24 |
Return on Assets (ROA) | -0.46 | -0.41 | -0.24 | -0.96 | -15.61 | -7.05 |
Return on Capital (ROIC) | -0.54 | -0.46 | -0.25 | -1.17 | 0.61 | 15.67 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a |